UAE Cardiovascular Devices Market Size (2024 - 2029)

The UAE cardiovascular devices market is projected to experience growth, driven by an increasing prevalence of cardiovascular diseases and advancements in technology. The market's expansion was notably affected by the COVID-19 pandemic, which initially reduced patient volumes due to lockdowns, but demand persisted as healthcare operations continued. The high incidence of cardiovascular conditions, exacerbated by lifestyle factors such as sedentary behavior and poor dietary habits, underscores the growing need for early diagnosis and treatment, thereby enhancing the market's potential.

Market Size of UAE Cardiovascular Devices Industry

UAE Cardiovascular Devices Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Historical Data Period 2019 - 2022
CAGR 5.90 %

Major Players

UAE Cardiovascular Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

UAE Cardiovascular Devices Market Analysis

The UAE cardiovascular devices market is expected to record a CAGR of 5.9% during the forecast period.

The COVID-19 pandemic impacted the market significantly. The market was adversely affected during the initial phase of the pandemic due to lockdowns and shutdowns and the reduction in patient volume. According to the study published in the Official Journal of the Gulf Heart Association in March 2021, there was a significant drop in acute coronary syndrome during the pandemic. This ranged from 30% to 60%. Such a reduction in patient volume impacted the demand for cardiovascular devices significantly, affecting the market's growth during the pandemic. However, the United Arab Emirates (UAE) government continued normal operations in the healthcare system following proper regulations and restrictions. Thus, these ongoing surgeries during the pandemic created a demand for cardiovascular devices. Therefore, the pandemic impacted the market considerably.

The key contributors to the market's growth are the growing burden of cardiovascular diseases and technological advancements. Cardiovascular diseases are one of the leading causes of mortality and morbidity in the UAE. Additionally, according to a survey result published in Gulf Insider in September 2021, over half of UAE citizens experienced heart disease at some point. More than a thousand UAE citizens participated in the study. The results showed 55% of those polled either had heart illness (12%), had a close friend or relative afflicted with the disease (53%), or experienced both. This burden of CVD among the target population in the country is anticipated to drive demand for cardiovascular devices, thereby contributing to the market's growth. As per the NCBI article published in December 2021, the study was conducted among several UAE residents, 57% of which mentioned that they do not involve vigorous activity, 66% frequently or consistently indulge in fast food, 65% take fried food as a main course, and 75% reported poor or fair practice considering CVD. These are major risk factors for CVD. In addition, as per the source mentioned above, the UAE has the second-highest cardiovascular mortality rate and is higher than the rate found in other Gulf Cooperation Council (GCC) countries. A sedentary lifestyle among the population is expected to add a burden.

Hence, the importance of early diagnosis and treatment is rising, boosting the cardiovascular devices market's growth in UAE.

UAE Cardiovascular Devices Industry Segmentation

As per the report's scope, cardiovascular devices are utilized to treat cardiovascular ailments that incorporate various issues. The UAE cardiovascular devices market is segmented by device type (diagnostic and monitoring devices (electrocardiogram (ECG), remote cardiac monitoring, and other diagnostic and monitoring devices) and therapeutic and surgical devices (cardiac assist devices, cardiac rhythm management devices, catheters, grafts, heart valves, stents, and other therapeutic and surgical devices). The report offers the value (USD million) for all the above segments.

By Device Type
Diagnostic and Monitoring Devices
Electrocardiogram (ECG)
Remote Cardiac Monitoring
Other Diagnostic and Monitoring Devices
Therapeutic and Surgical Devices
Cardiac Assist Devices
Cardiac Rhythm Management Device
Catheter
Grafts
Other Therapeutic and Surgical Devices
Need A Different Region Or Segment?
Customize Now

UAE Cardiovascular Devices Market Size Summary

The UAE cardiovascular devices market is poised for growth, driven by the increasing prevalence of cardiovascular diseases and advancements in medical technology. The market experienced a significant impact during the COVID-19 pandemic, with initial disruptions due to lockdowns and reduced patient volumes. However, the UAE government's efforts to maintain healthcare operations and the ongoing need for surgeries helped sustain demand for cardiovascular devices. The rising burden of cardiovascular diseases, exacerbated by lifestyle factors such as obesity and sedentary habits, is a key driver of market expansion. The importance of early diagnosis and treatment is becoming increasingly critical, further propelling the demand for advanced cardiovascular devices.

Technological innovations, particularly in the electrocardiogram (ECG) segment, are expected to significantly contribute to market growth. The development of advanced devices with Bluetooth sensors and mobile app integration is enhancing diagnostic capabilities. Additionally, the growing need for remote cardiac monitoring, driven by the high prevalence of heart disease and an aging population, is fostering segment expansion. Awareness campaigns and strategic partnerships among key industry players are also playing a crucial role in promoting cardiovascular health and advancing remote monitoring solutions. The market is moderately consolidated, with major global and regional companies actively participating in the UAE's healthcare landscape.

Explore More

UAE Cardiovascular Devices Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Technological Advancements and Rising Preference for Minimally Invasive Procedures

      2. 1.2.2 Increasing Burden of Cardiovascular Diseases

    3. 1.3 Market Restraints

      1. 1.3.1 Stringent Regulatory Policies and High Cost of Instruments and Procedures

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD Million)

    1. 2.1 By Device Type

      1. 2.1.1 Diagnostic and Monitoring Devices

        1. 2.1.1.1 Electrocardiogram (ECG)

        2. 2.1.1.2 Remote Cardiac Monitoring

        3. 2.1.1.3 Other Diagnostic and Monitoring Devices

      2. 2.1.2 Therapeutic and Surgical Devices

        1. 2.1.2.1 Cardiac Assist Devices

        2. 2.1.2.2 Cardiac Rhythm Management Device

        3. 2.1.2.3 Catheter

        4. 2.1.2.4 Grafts

        5. 2.1.2.5 Other Therapeutic and Surgical Devices

UAE Cardiovascular Devices Market Size FAQs

The UAE Cardiovascular Devices Market is projected to register a CAGR of 5.90% during the forecast period (2024-2029)

Abbott Laboratories, Advanced Healthcare LLC, GE Healthcare, Al Naghi Medical Co. and Medtronic PLC are the major companies operating in the UAE Cardiovascular Devices Market.

UAE Cardiovascular Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)